JP7527109B2 - 造血幹細胞移植を受けている患者を治療するための便細菌叢 - Google Patents

造血幹細胞移植を受けている患者を治療するための便細菌叢 Download PDF

Info

Publication number
JP7527109B2
JP7527109B2 JP2019540408A JP2019540408A JP7527109B2 JP 7527109 B2 JP7527109 B2 JP 7527109B2 JP 2019540408 A JP2019540408 A JP 2019540408A JP 2019540408 A JP2019540408 A JP 2019540408A JP 7527109 B2 JP7527109 B2 JP 7527109B2
Authority
JP
Japan
Prior art keywords
sample
transplantation
fecal microbiota
hsc
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019540408A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020506183A5 (https=
JP2020506183A (ja
Inventor
モーティ モハマド
ソコル ハリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sorbonne Universite
Original Assignee
Sorbonne Universite
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59325347&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP7527109(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sorbonne Universite filed Critical Sorbonne Universite
Publication of JP2020506183A publication Critical patent/JP2020506183A/ja
Publication of JP2020506183A5 publication Critical patent/JP2020506183A5/ja
Application granted granted Critical
Publication of JP7527109B2 publication Critical patent/JP7527109B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2019540408A 2017-01-26 2018-01-26 造血幹細胞移植を受けている患者を治療するための便細菌叢 Active JP7527109B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1750629 2017-01-26
FR1750629A FR3062063B1 (fr) 2017-01-26 2017-01-26 Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques
PCT/EP2018/051941 WO2018138251A1 (fr) 2017-01-26 2018-01-26 Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques

Publications (3)

Publication Number Publication Date
JP2020506183A JP2020506183A (ja) 2020-02-27
JP2020506183A5 JP2020506183A5 (https=) 2022-12-02
JP7527109B2 true JP7527109B2 (ja) 2024-08-02

Family

ID=59325347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019540408A Active JP7527109B2 (ja) 2017-01-26 2018-01-26 造血幹細胞移植を受けている患者を治療するための便細菌叢

Country Status (20)

Country Link
US (1) US20200188450A1 (https=)
EP (1) EP3573631B1 (https=)
JP (1) JP7527109B2 (https=)
KR (1) KR102517287B1 (https=)
CN (1) CN110520141A (https=)
AU (1) AU2018212530B2 (https=)
CA (1) CA3051807C (https=)
DK (1) DK3573631T3 (https=)
ES (1) ES2937965T3 (https=)
FI (1) FI3573631T3 (https=)
FR (1) FR3062063B1 (https=)
HR (1) HRP20230122T1 (https=)
HU (1) HUE061155T2 (https=)
IL (1) IL268237B (https=)
LT (1) LT3573631T (https=)
PL (1) PL3573631T3 (https=)
PT (1) PT3573631T (https=)
RS (1) RS63978B1 (https=)
SI (1) SI3573631T1 (https=)
WO (1) WO2018138251A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020530494A (ja) * 2017-08-07 2020-10-22 フィンチ セラピューティクス、インコーポレイテッド． 健康な腸バリアを維持及び回復するための組成物及び方法
US20220023419A1 (en) * 2018-11-28 2022-01-27 The Council Of The Queensland Institute Of Medical Research Inhibiting inflammation
CN112375705A (zh) * 2020-11-12 2021-02-19 安徽燕婉健康科技有限公司 一种替代天然菌群的肠壁移植优势菌的制备方法及其应用
EP4386090A1 (en) * 2022-12-12 2024-06-19 Assistance Publique - Hôpitaux De Paris Method for determining and improving the potential efficacy of anticancer treatment

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160143961A1 (en) 2014-11-25 2016-05-26 Epiva Biosciences, Inc. Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649719B1 (fr) * 1989-07-17 1993-08-27 Cerbio Sa Procede de protection et de conservation de micro-organismes notamment de bacteries
US9968638B2 (en) * 2011-03-09 2018-05-15 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
EP2922555A4 (en) * 2012-11-26 2016-06-15 Borody Thomas J COMPOSITIONS FOR THE RESTORATION OF A FÄKALBIOZÖNOSE AND METHOD FOR THE PRODUCTION AND USE THEREOF
WO2016057671A1 (en) * 2014-10-07 2016-04-14 University Of Virginia Patent Foundation Compositions and methods for preventing and treating infection
WO2016086161A1 (en) * 2014-11-25 2016-06-02 Memorial Sloan-Kettering Cancer Center Intestinal microbiota and gvhd
FR3035328B1 (fr) 2015-04-24 2019-08-23 Maat Pharma Procede de preparation d'un echantillon de microbiote fecal
JP6408092B2 (ja) * 2016-08-29 2018-10-17 国立大学法人 東京大学 糞便微生物叢を含む組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160143961A1 (en) 2014-11-25 2016-05-26 Epiva Biosciences, Inc. Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ＢＬＯＯＤ，２０１６年１０月，ＶＯＬ：１２８，ＮＲ：１６，ＰＡＧＥ（Ｓ）：２０８３－２０８８
Ｔｒａｎｓｐｌａｎｔ Ｉｎｆｅｃｔｉｏｕｓ Ｄｉｓｅａｓｅ，２０１６年０７月，１８（４），ｐ．６２８－６３３

Also Published As

Publication number Publication date
US20200188450A1 (en) 2020-06-18
IL268237A (en) 2019-09-26
EP3573631B1 (fr) 2022-11-16
LT3573631T (lt) 2023-03-10
IL268237B (en) 2022-07-01
FR3062063B1 (fr) 2019-04-19
PL3573631T3 (pl) 2023-05-02
AU2018212530A1 (en) 2019-09-05
KR102517287B1 (ko) 2023-03-31
CN110520141A (zh) 2019-11-29
CA3051807A1 (fr) 2018-08-02
HUE061155T2 (hu) 2023-05-28
DK3573631T3 (da) 2023-01-30
FI3573631T3 (fi) 2023-03-02
PT3573631T (pt) 2023-01-24
KR20190130563A (ko) 2019-11-22
ES2937965T3 (es) 2023-04-03
RS63978B1 (sr) 2023-03-31
AU2018212530B2 (en) 2022-06-23
WO2018138251A1 (fr) 2018-08-02
FR3062063A1 (fr) 2018-07-27
CA3051807C (fr) 2023-07-11
HRP20230122T1 (hr) 2023-03-31
EP3573631A1 (fr) 2019-12-04
JP2020506183A (ja) 2020-02-27
SI3573631T1 (sl) 2023-09-29

Similar Documents

Publication Publication Date Title
JP6858747B2 (ja) 便微生物試料を調製する方法
KR102341203B1 (ko) 분변 미생물총의 샘플의 동결건조 방법
JP7527109B2 (ja) 造血幹細胞移植を受けている患者を治療するための便細菌叢
CN104918624A (zh) 恢复排泄物微生物群的组合物及其制造和使用方法
US20200038459A1 (en) Composition comprising fecal microbiota
US20260115237A1 (en) Probiotic composition for preventing and treating anti-tumor treatment-related diarrhea and use thereof
Daniluk et al. Probiotic-induced apoptosis and its potential relevance to mucosal inflammation of gastrointestinal tract
Zhang et al. Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia.
CN115317518A (zh) 一种肠道微生物增强调节性b细胞对心脏移植排斥反应治疗作用的方法
US20230043598A1 (en) Capsule comprising a faecal composition
Moreau et al. Early intensive therapy with autotransplantation for high-risk Hodgkin's disease
US20100129329A1 (en) METHODS FOR USING ALDHbr CELLS TO SUPPLEMENT STEM CELL TRANSPLANTATION
EP1881838B1 (en) Antitumor agent on the base of bcg vaccine, method for its preparation and its use
Park et al. Improved survival in patients with recurrent Wilms tumor: the experience of the Seoul National University Children's Hospital
Lehn et al. Bone marrow transplantation for chronic granulocytic leukemia
Sinitsyn et al. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization
Sung et al. Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center
CN121014615A (zh) 一种经血保存液及经血来源间充质干细胞冻存方法
e FAMILY et al. Disease free survival in paediatric malignant disorders with cost effective care after haploidentical stem cell transplantation with post-transplant cyclophosphamide: a single centre experience from south India
Kido et al. Allogeneic and autologous stem cell transplantation in advanced small round cell sarcomas
Schneiderman et al. 222: Donor Chimerism Kinetics in Pediatric Patients Undergoing Reduced Intensity Conditioning (RIC) with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Kennedy-Nasser et al. 223: Alternative Donor Hematopoietic Stem Cell Transplantation for Pediatric Patients with Acute Lymphoblastic Leukemia Using Campath in a Myeloablative Conditioning Regimen
Ghavamzadeh et al. Gastrointestinal Bleeding, the First Presentation of Acute GVHD in Two Patients with Thalassemia after BMT
Litzow 15 Blood and Marrow Transplantation
Shah et al. Hematopoietic Stem Cell Transplantation in the PICU

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201214

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211130

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220224

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220315

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220712

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20221114

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20221114

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221118

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20221208

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20221213

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20221228

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20230110

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240723

R150 Certificate of patent or registration of utility model

Ref document number: 7527109

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S201 Request for registration of exclusive licence

Free format text: JAPANESE INTERMEDIATE CODE: R314201

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350